Prestige Consumer Healthcare (PBH) Invested Capital (2013 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Invested Capital of $21.3 million for Q4 2025, up 327.29% year-over-year from $5.0 million in Q4 2024, and down 2.86% quarter-over-quarter from $21.9 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Invested Capital (2013 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Invested Capital history runs 10 years deep, the most recent figure standing at $21.3 million for Q4 2025.
- In Q4 2025, Invested Capital rose 327.29% year-over-year to $21.3 million; the TTM figure through Dec 2025 stood at $88.8 million (up 1037.58% YoY), while the FY2025 annual figure was $23.1 million, up 1287.39% from the prior year.
- Invested Capital for Q4 2025 stood at $21.3 million, down from $21.9 million in the prior quarter.
- The five-year high for Invested Capital was $23.1 million in Q1 2025, with the low at $217000.0 in Q3 2024.
- The 5-year median for Invested Capital is $6.2 million (2022), against an average of $8.5 million.
- The sharpest annual moves came in 2024 and 2025: Invested Capital slumped 92.99% in 2024, then surged 9988.02% in 2025.
- Prestige Consumer Healthcare's Invested Capital stood at $7.5 million in 2021, then tumbled by 30.44% to $5.2 million in 2022, then tumbled by 54.15% to $2.4 million in 2023, then soared by 108.85% to $5.0 million in 2024, then jumped by 327.29% to $21.3 million in 2025.
- Business Quant data shows PBH's Invested Capital at $21.3 million in Q4 2025, $21.9 million in Q3 2025, and $22.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 630.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.27 Mn |
| Sep 30, 2025 | 21.89 Mn |
| Jun 30, 2025 | 22.51 Mn |
| Mar 31, 2025 | 23.11 Mn |
| Dec 31, 2024 | 4.98 Mn |
| Sep 30, 2024 | 217,000.00 |
| Jun 30, 2024 | 944,000.00 |
| Mar 31, 2024 | 1.67 Mn |
| Dec 31, 2023 | 2.38 Mn |
| Sep 30, 2023 | 3.09 Mn |
| Jun 30, 2023 | 3.80 Mn |
| Mar 31, 2023 | 4.50 Mn |
| Dec 31, 2022 | 5.20 Mn |
| Sep 30, 2022 | 5.89 Mn |
| Jun 30, 2022 | 6.57 Mn |
| Mar 31, 2022 | 7.25 Mn |
| Dec 31, 2021 | 7.47 Mn |
| Sep 30, 2021 | 8.12 Mn |
| Jun 30, 2021 | 8.76 Mn |
| Mar 31, 2021 | 9.40 Mn |